BBP ETF (Virtus LifeSci Biotech Products ETF) is managed by Virtus Investment Partners with $95.2M in net assets. BBP expense ratio is 0.34%, holding 62 positions across sectors including Health Care, Unknown, Other. Inception date: 2014-12-16.

BBP performance shows a YTD return of 20.98%. The 1-year return is 65.06% and the 5-year return is 12.55%.

BBP top holdings include Immunitybio Inc (5.7%), Moderna therapeutics (2.9%), Iovance Biotherapeutics Inc (2.6%), Mirum Pharmaceuticals Inc (2.6%), Kalvista Pharmaceuticals Inc (2.5%). View all BBP holdings, sector breakdown, or dividend history.

BBP can be compared against other funds using the overlap calculator or side-by-side comparison tool. BBP alternatives are available via the screener, along with tax-loss harvesting opportunities.